ESPR icon

Esperion Therapeutics

142 hedge funds and large institutions have $598M invested in Esperion Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 45 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

26% less capital invested

Capital invested by funds: $805M → $598M (-$206M)

30% less call options, than puts

Call options by funds: $14.9M | Put options by funds: $21.3M

42% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 31

Holders
142
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14.9M
Puts
$21.3M
Net Calls
Net Calls Change

Top Buyers

1 +$11.2M
2 +$8.46M
3 +$5.9M
4
Marshall Wace
Marshall Wace
United Kingdom
+$3.01M
5
MG
Meditor Group
Bermuda
+$2.94M

Top Sellers

1 -$18.2M
2 -$10.5M
3 -$7.43M
4
PCM
Pentwater Capital Management
Florida
-$6.73M
5
Axa
Axa
France
-$3.57M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$2.79M
27
$2.21M
28
$2.11M
29
$2.09M
30
$1.88M
31
$1.77M
32
$1.59M
33
$1.59M
34
$1.56M
35
$1.37M
36
$1.36M
37
$1.33M
38
$1.27M
39
$1.17M
40
$1.12M
41
$1.11M
42
$1.07M
43
$1.05M
44
$967K
45
$952K
46
$830K
47
$814K
48
$799K
49
$785K
50
$765K